$BIIB Recent News This tiny biotech company takes the

New Post Public Reply Private Reply Replies (0) Message Board

Sep 2, 2014 at 10:40 AM

$BIIB Recent News

This tiny biotech company takes the real ice bucket challenge 25 min ago - Michael Brush
5 companies that will benefit from ALS awareness 7:58 a.m. Aug. 22, 2014 - Jennifer Booton
Biogen results crush consensus 4:55 p.m. July 23, 2014 - The Trading Deck
S&P 500 closes at record on strong earnings 4:23 p.m. July 23, 2014 - Anora Mahmudova
Apple, Intuitive power S&P 500 to record: stock market live blog recap 4:17 p.m. July 23, 2014 - blogs.marketwatch.com
Biogen rallies on earnings; Juniper slumps 10% 1:25 p.m. July 23, 2014 - Sue Chang
Biogen earnings: A lesson in how to boost an already pricey stock 10:49 a.m. July 23, 2014 - Russ Britt
Biogen Idec shares rally 12% 9:32 a.m. July 23, 2014 - Sue Chang
Biogen Idec shares up 7% in premarket trade after earnings 7:39 a.m. July 23, 2014 - Ciara Linnane
Biogen Idec's profit, sales blow past estimates 7:20 a.m. July 23, 2014 - MarketWatch.com
Biogen Idec shares rally 5.4% in premarket trade after earnings 6:53 a.m. July 23, 2014 - Tomi Kilgore
One lesson for investors from the 1990s bubble 3:13 p.m. June 19, 2014 - The Trading Deck
Tyson rallies after jumping into Hillshire chase 3:44 p.m. May 29, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. April 29, 2014 - Barbara Kollmeyer
Investors gloss over Biogen earnings miss and focus on MS drug sales 2:23 p.m. April 23, 2014 - Russ Britt
Scouring the moonscape for leading stocks 3:02 p.m. April 22, 2014 - The Trading Deck
Apple, Microsoft are not the keys to this week’s news 7:00 a.m. April 22, 2014 - Marek Fuchs
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski

Today's Market: Red Hot Biotech And Big Pharma Names To Watch 8:22 a.m. Aug. 29, 2014 - Seeking Alpha
Biotech Stocks 101 — What Investors Need to Know 6:59 a.m. Aug. 29, 2014 - InvestorPlace.com
Rising Short Interest in Biotech Stocks 9:42 a.m. Aug. 27, 2014 - 247WallSt.com
After Recent Surge, Are Biotech ETFs Back on Track? - ETF News And Commentary 8:00 a.m. Aug. 27, 2014 - Zacks.com
Celgene, Gilead Lead Big Biotech Stock Movers 1:38 p.m. Aug. 26, 2014 - Investors Business Daily
Health Canada Approves Eloctate(TM), the First Therapy to Extend the Interval Between Prophylactic Infusions in Hemophilia A 8:00 a.m. Aug. 26, 2014 - CNW Group
Biogen, Celgene In Buy Range; LinkedIn Coming Back 5:43 p.m. Aug. 25, 2014 - Investors Business Daily
Majority Of IBD 50 Firms Strong On Sponsorship 5:37 p.m. Aug. 22, 2014 - Investors Business Daily
Majority Of IBD 50 Firms Strong On Sponsorship 5:37 p.m. Aug. 22, 2014 - Investors Business Daily
Data on Celgene's Revlimid Published in Oncology Journal - Analyst Blog 5:35 p.m. Aug. 22, 2014 - Zacks.com
What Investors Gain from Large, Mid & Small-Cap Growth Funds - Mutual Fund Commentary 3:02 p.m. Aug. 20, 2014 - Zacks.com
3 Drugs Stocks Dragging The Industry Down 1:04 p.m. Aug. 20, 2014 - TheStreet.com
Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Analyst Blog 11:08 a.m. Aug. 20, 2014 - Zacks.com
6 Biotech Stocks to Buy Now With Up to 100% Upside Potential 7:41 a.m. Aug. 20, 2014 - 247WallSt.com
Biogen Strengthens MS Portfolio with Plegridy FDA Approval - Analyst Blog 1:20 p.m. Aug. 19, 2014 - Zacks.com
Why Biogen Idec (BIIB) Stock Is Gaining Today 11:44 a.m. Aug. 18, 2014 - TheStreet.com
UPDATE: Morgan Stanley Reiterates On Biogen Idec Following Plegridy Approval 6:50 a.m. Aug. 18, 2014 - benzinga.com
Hottest Healthcare Stocks Now – PTCT LGND WX BIIB 1:45 p.m. Aug. 15, 2014 - InvestorPlace.com
Today's Momo Momentum Stock Is Biogen Idec (BIIB) 9:49 a.m. Aug. 15, 2014 - TheStreet.com
Perrigo Regains Some Lost Ground On Fiscal Q4 Beat 5:36 p.m. Aug. 14, 2014 - Investors Business Daily

Upcoming Conferences Schedule, Clinical Trial Data Release Schedule, Milestone Payment, and Expansion of Partnership - Research Reports on Celgene, Actavis, Regeneron, ISIS and UnitedHealth 9:10 a.m. Aug. 29, 2014 - PR Newswire - PRF
Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 4:55 p.m. Aug. 26, 2014 - PR Newswire - PRF
Biogen Idec in Panel at the Citi 9th Annual Biotech Conference 4:02 p.m. Aug. 26, 2014 - BusinessWire - BZX
Donald Johns Joins Biogen Idec to Lead ALS Innovation Hub 8:00 a.m. Aug. 26, 2014 - BusinessWire - BZX
Biogen Idec Names Adriana Karaboutis EVP, Technology and Business Solutions 7:00 a.m. Aug. 21, 2014 - BusinessWire - BZX
Drug Approvals, Clinical Trial Result, and Philanthropic Activity - Research Reports on Johnson & Johnson, Biogen, Amgen, Medtronic and Merck 9:20 a.m. Aug. 20, 2014 - PR Newswire - PRF
Biogen Idec’s PLEGRIDY™(Peginterferon Beta-1a) Approved in the US for the Treatment of Multiple Sclerosis 6:44 p.m. Aug. 15, 2014 - BusinessWire - BZX
Biogen Idec’s PLEGRIDY™(Peginterferon Beta-1a) Approved in the US for the Treatment of Multiple Sclerosis 6:32 p.m. Aug. 15, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy 7:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Rush University Medical Center Sells AMPYRA® Royalty Rights to DRI Capital Managed Fund for Approximately $42 Million 8:02 a.m. Aug. 12, 2014 - BusinessWire - BZX
Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma 8:40 a.m. Aug. 11, 2014 - PR Newswire - PRF
The Launch of Five Immunomodulatory Therapies for Relapsing Forms of Multiple Sclerosis Will Contribute to 4 Percent Annual Growth of the Total Market from 2013 to 2023 1:00 p.m. Aug. 7, 2014 - PR Newswire - PRF
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth 9:13 a.m. Aug. 5, 2014 - PR Newswire - PRF
Regulus Enters Into New Collaboration Agreement with Biogen Idec to Identify microRNA Biomarkers in Multiple Sclerosis 8:00 a.m. Aug. 5, 2014 - PR Newswire - PRF
BioMed Realty Trust To Webcast Investor Day 2014 8:00 a.m. Aug. 4, 2014 - PR Newswire - PRF
Favorable Court Ruling, Quarterly Performance Reviews, Acquisition Completion, and Contract Renewals - Research Reports on Mylan, Biogen, Medtronic, UnitedHealth and Covidien 9:20 a.m. Aug. 1, 2014 - PR Newswire - PRF
RBCC 3D Bioprinting Partner Awarded Prestigious Grant 6:54 a.m. July 31, 2014 - BusinessWire - BZX
Proteostasis Therapeutics Announces Achievement of Preclinical Milestone in Neurodegenerative Diseases Collaboration With Biogen Idec 5:30 a.m. July 30, 2014 - Marketwire
PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis 11:41 a.m. July 23, 2014 - BusinessWire - BZX
Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 12:00 p.m. July 22, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Calavera NY Website Revamp: Gemstone Expansion Hits

Calavera New York's Bold Online Makeover When a jewelry brand that's all about slashing retail markups makes a move this big, it's worth a real close-up look. Calavera New York, a name buzzing in the diamond and gemstone scene, just dropped a redesigned website that’s turning more than a few heads. They’re known for cutting out the middleman, a strategy that already...

IRS Views Challenge Tax-Engineered Healthcare Schemes

Nonprofit Models Shine Amid IRS Scrutiny Out in Oxnard, California, there's a brewing storm in the healthcare sector. No, it's not a billing error or yet another scandal. We're talking about a seismic shift that could poke holes in those tax-engineered Section 105(b) programs, all thanks to some hard-hitting IRS memoranda. The Nonprofit–TPA Model: A Safer Bet? Enter...

Menopause Policy Advocacy Takes Center Stage in DC

Unlikely Spotlight on Menopause at Capitol Hill If you told me a couple of years back that menopause would become a front-page political issue, I would've laughed. Yet, here we are, with over 125 advocates from 29 states converging on Washington, D.C., demanding legislative action on menopause. Why Menopause Matters in Policy The fact that more than half the population is...

Bellissima Bags Allure Award for Curly Hair Tool

Award-Winning Tool Headlines 2026 Beauty Scene There's a shake-up in the world of hair tools, folks. Bellissima's Diffon Supreme has snagged a 2026 Allure Best of Beauty Award for its prowess in taming the curly, wavy, and coily strands we all crave to manage. Performance Meets Innovation in Bellissima's Latest Let's not beat around the bush. The Diffon Supreme's trump...

Ensuring Your Radon Mitigation System Stays Effective

Radon Mitigation: A Critical Measure for Home Safety Homeowners, you're probably aware of the ticking health time bomb known as radon. Not just an annoying gas, this colorless, odorless beast lurks quietly, threatening family health if not managed right. Mitch Kelley, a specialist in radon testing with Basement Solutions in Mankato, Minnesota, lays out a no-fuss guide to...

Buffett Steps Down, New Faces at Berkshire Hathaway

End of an Era: Warren Buffett's Retirement Warren Buffett—there's a name that's echoed through the halls of investment for decades. Today, he's pulling down the curtain as Chairman of Berkshire Hathaway (NYSE: BRK). No fanfare, just a nod to the inevitable with his classic, humor-tinged confession: 'Father Time always wins.' Can’t argue with the man who’s seen the...

AI Ambassadors Rethink Arbitration's Future

Navigating the AI Terrain in Arbitration It's 2026 and artificial intelligence isn't just a buzzword anymore; it's reshaping every corner of how disputes get resolved. The American Arbitration Association (AAA) has jumped into the mix, launching an AI Ambassador program to tackle a wave of AI-induced challenges. These aren't just academic exercises—this is a hard-nosed...

Sierra Ridge Advisors Join Gateway Financial Milestone

Big Moves in the Financial Advisory World Let's dive right in. Here's a real shakeup in the advisory realm: 28 financial advisors and team members from Sierra Ridge Advisor Group are packing their bags for Gateway Financial Partners. We're talking about a significant shift involving $825 million in assets under advisement. Instead of sticking with Sierra Ridge as it...

Kobold Press Explores Roleplaying as Literacy Tool

Gaming Illuminates Pathways to Literacy and Community Trust me, when an indie game publisher like Kobold Press makes waves, it's worth paying attention. They've carved a niche in the roleplaying world by marrying traditional game elements with valuable educational tools. The thrill of the game goes beyond rolling dice; it's a ticket to improving literacy, arithmetic, and...

Arizona Voters Demand Clear Plans for 2026 Election

A Shift in Voter Expectations: Clear Actions Needed Arizona voters have spoken, and they aren't looking for the same old political song and dance anymore. They crave something meatier—action, not just words. Heading into the 2026 general election, folks in the Grand Canyon State are demanding concrete solutions and straightforward answers from those who seek to lead...